US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat.
The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
  • Biopharmaceuticals (221)
  • Diseases & Conditions (4429)
  • Drug Delivery (186)
  • Therapeutic Area (7020)
  • Vaccines (643)
RSS Feeds

Pharmaceuticals Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Out-of-Pocket Healthcare Expenditures in the United States
5/15/2015 | published by: Kalorama Information
... is the result of a variety of factors including an aging U.S. population, rising utilization of medical products and services, and ongoing cutbacks to both public (federal and state) and private health coverage. Over the ...  |  read more...
USD 1,500
Cardiac Rhythm Management Device Markets
5/1/2015 | published by: Kalorama Information
... particularly arrhythmias and congestive heart failure. This report,  C ardiac Rhythm Device Markets,  includes cardiac rhythm management devices with both external and internal applications.  Major segments include defibrillators: electrical devices that deliver therapeutic levels of ...  |  read more...
USD 3,995
Neuro Endocrine (Carcinoid) Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuro Endocrine (Carcinoid) Carcinoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Neuroendocrine Carcinoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuroendocrine Carcinoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neuroendocrine Carcinoma- Pipeline ...  |  read more...
USD 1,250
Neurofibromatoses-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Neurofibromatoses Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neurofibromatoses- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
2015 U.S. Patient care - Infectious & parasitic diseases sold through Medical & surgical hospitals-Product & Services Report
5/15/2015 | published by: Barnes Reports
... The report features 2015 current and 2016 forecast estimates on the sales of Patient care - Infectious & parasitic diseases sold through Medical & surgical hospitals nationally and for all 50 U.S. States and up ...  |  read more...
USD 199
Nocturia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Nocturia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Nocturia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Non Muscle Invasive Bladder ...  |  read more...
USD 1,250
2015 U.S. Patient care - Endocrine, nutritional, & metabolic disorders sold through Medical & surgical hospitals-Product & Services Report
5/15/2015 | published by: Barnes Reports
... demographics. The report features 2015 current and 2016 forecast estimates on the sales of Patient care - Endocrine, nutritional, & metabolic disorders sold through Medical & surgical hospitals nationally and for all 50 U.S. States ...  |  read more...
USD 199
Muscarinic Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Muscarinic Agonists- ...  |  read more...
USD 1,250
Muscarinic M1 Agonists -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Muscarinic M1 Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive ...  |  read more...
USD 1,250
Non-Alcoholic Steatohepatitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Non-Alcoholic Steatohepatitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Non-Alcoholic Steatohepatitis- Pipeline ...  |  read more...
USD 1,250
Nonhematologic Malignancy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Nonhematologic Malignancy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Nonhematologic Malignancy- Pipeline ...  |  read more...
USD 1,250
Non-Union Fractures-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Non-Union Fractures Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Non-Union Fractures- Pipeline ...  |  read more...
USD 1,250
Ocular Hypertension-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Ocular Hypertension Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Ocular Hypertension- Pipeline ...  |  read more...
USD 1,250
Onychomycosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Onychomycosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Onychomycosis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Opioid Induced Bowel Dysfunction-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Opioid Induced Bowel Dysfunction Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Optic Nerve Injury-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Optic Nerve Injury Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Optic Neuritis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Optic Neuritis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Optic Neuritis- Pipeline ...  |  read more...
USD 1,250
Osteonecrosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Osteonecrosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Osteonecrosis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Osteopenia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Osteopenia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Osteopenia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Pancreatitis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Pancreatitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Pancreatitis- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Panic Disorders-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Panic Disorders Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Panic Disorders- Pipeline ...  |  read more...
USD 1,250
Papillary Thyroid Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Papillary Thyroid Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Myosin Inhibitors -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Myosin Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Myosin Inhibitors- ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10